Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy-Reference-Cited by-同舟云学术

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

Published:2013-07-24 Issue:3 Volume:58 Page:923-931
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Seto Wai-Kay¹,Wong Danny Ka-Ho,Fung James,Huang Fung-Yu¹,Lai Ching-Lung,Yuen Man-Fung

Affiliation:

1. Department of Medicine; and the University of Hong Kong, Queen Mary Hospital; Hong Kong

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26376/fullpdf

Reference30 articles.

1. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group;Lai;N Engl J Med,1998

2. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B;Lai;N Engl J Med,2006

3. Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety;Yuen;Am J Gastroenterol,2011

4. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B;Heathcote;Gastroenterology,2011

5. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments;Gastrointestinal Disorders;2024-09-12

2. Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity;Journal of Viral Hepatitis;2024-09-09

3. Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review;Journal of Viral Hepatitis;2024-08-16

4. Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis;The Journal of Infectious Diseases;2024-07-05

5. Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B;Journal of Hepatology;2024-07